** Brokerage Jefferies trim price target on Australia's Monash IVF MVF.AX to A$1.25 per share from A$1.45 per share
** Monash on Tuesday, downgraded its FY25 underlying NPAT forecast to about A$27.5 million ($17.69 million), from its previous forecast of A$30.0 million to A$31.0 million
** Believe this is in part due to the somewhat discretionary nature of IVF as well as MVF’s exposure to Victoria, a state that is facing economic challenges - Jefferies
** Six of seven analysts rate the stock "buy" or higher, one "hold"; their median PT is A$1.17, according to data compiled by LSEG
** Stock has fallen 39.4% this year, as of last close
($1 = 1.5545 Australian dollars)
(Reporting by Roshan Thomas in Bengaluru)
((Roshan.Thomas@thomsonreuters.com))
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。